Your browser doesn't support javascript.
loading
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma.
Krabbe, Laura-Maria; Heitplatz, Barbara; Preuss, Sina; Hutchinson, Ryan C; Woldu, Solomon L; Singla, Nirmish; Boegemann, Martin; Wood, Christopher G; Karam, Jose A; Weizer, Alon Z; Raman, Jay D; Remzi, Mesut; Rioux-Leclercq, Nathalie; Haitel, Andrea; Rapoport, Leonid M; Glybochko, Peter V; Roscigno, Marco; Bolenz, Christian; Bensalah, Karim; Sagalowsky, Arthur I; Shariat, Shahrokh F; Lotan, Yair; Xylinas, Evanguelos; Margulis, Vitaly.
Afiliación
  • Krabbe LM; Department of Urology, University of Muenster Medical Center, Muenster, Germany; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Heitplatz B; Department of Pathology, University of Muenster Medical Center, Muenster, Germany.
  • Preuss S; Department of Urology, University of Muenster Medical Center, Muenster, Germany.
  • Hutchinson RC; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Woldu SL; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Singla N; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Boegemann M; Department of Urology, University of Muenster Medical Center, Muenster, Germany.
  • Wood CG; Department of Urology, M. D. Anderson Cancer Center, Houston, Texas.
  • Karam JA; Department of Urology, M. D. Anderson Cancer Center, Houston, Texas.
  • Weizer AZ; Department of Urology, University of Michigan Cancer Center, Ann Arbor, Michigan.
  • Raman JD; Division of Urology, Penn State Health Milton S.Hershey Medical Center, Hershey, Pennsylvania.
  • Remzi M; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Rioux-Leclercq N; Department of Pathology, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Haitel A; Department of Pathology, Medical University Vienna, Vienna, Austria.
  • Rapoport LM; Department of Uronephrology and Reproductive Health, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Glybochko PV; Department of Uronephrology and Reproductive Health, Sechenov First Moscow State Medical University, Moscow, Russia.
  • Roscigno M; Department of Urology, Ospedali Riuniti of Bergamo, Bergamo, Italy.
  • Bolenz C; Department of Urology, University of Ulm, Ulm, Germany.
  • Bensalah K; Department of Urology, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Sagalowsky AI; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Shariat SF; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Lotan Y; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Xylinas E; Department of Urology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France.
  • Margulis V; Department of Urology, University of Texas Medical Center, Dallas, Texas. Electronic address: Vitaly.margulis@utsouthwestern.edu.
J Urol ; 198(6): 1253-1262, 2017 12.
Article en En | MEDLINE | ID: mdl-28668287

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Carcinoma de Células Transicionales / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Carcinoma de Células Transicionales / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article
...